On the potential involvement of CD11d in co-stimulating the production of interferon-γ by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3

Haematologica

Volumn 96, Issue 10, 2011, Pages 1543-1547

  Costantini, Claudio ^a   Micheletti, Alessandra ^a   Calzetti, Federica ^a   Perbellini, Omar ^a   Tamassia, Nicola ^a   Albanesi, Cristina ^b   Vermi, William ^c   Cassatella, Marco A ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

CD11d; IFN ; Neutrophil; NK cell; SlanDC; Sweet's syndrome

Indexed keywords

CD11 ANTIGEN; CD11D ANTIGEN; CD18 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ARTICLE; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE ACTIVATION; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENESIS; PROTEIN FUNCTION;

ANTIGENS, CD; ANTIGENS, CD11; ANTIGENS, CD11A; ANTIGENS, CD18; CELL ADHESION MOLECULES; CELL COMMUNICATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; INTEGRIN ALPHA CHAINS; INTERFERON-GAMMA; INTERLEUKIN-12; KILLER CELLS, NATURAL; LECTINS, C-TYPE; NEUTROPHILS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; SWEET SYNDROME;

EID: 79960813692     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.044578     Document Type: Article

References (21)

1. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010; 10(6):427-439.
2. Boudaly S. Activation of dendritic cells by polymorphonuclear neutrophils. Front Biosci. 2009;14:1589-1595.
3. Costantini C, Cassatella MA. The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol. 2011;89(2):221-233.
4. Muller I, Munder M, Kropf P, Hansch GM. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 2009;30(11):522-530.
5. Costantini C, Calzetti F, Perbellini O, Micheletti A, Scarponi C, Lonardi S, et al. Human neutrophils interact with both 6- sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood. 2011;117(5): 1677-1686.
6. Fawcett J, Holness CL, Needham LA, Turley H, Gatter KC, Mason DY, et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature. 1992;360(6403): 481-484.
7. Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St John T, et al. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature. 1992;360(6403):485-488.
8. Van der Vieren M, Le Trong H, Wood CL, Moore PF, St John T, Staunton DE, et al. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity. 1995;3(6):683-690.
9. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100(5):575-585.
10. Werther WA, Gonzalez TN, O'Connor SJ, McCabe S, Chan B, Hotaling T, et al. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1. J Immunol. 1996;157(11):4986-4995.
11. Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, et al. Efalizumab binding to the LFA- 1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci USA. 2009;106(11):4349-4354.
12. Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SK, et al. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest. 1999;103(1):97-106.
13. Bolomini-Vittori M, Montresor A, Giagulli C, Staunton D, Rossi B, Martinello M, et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol. 2009;10(2):185-194.
14. Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol. 2002;76(4):1866-1875.
15. Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N, et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J Immunol. 2002;168(6): 2634-2643.
16. Tamassia N, Le Moigne V, Rossato M, Donini M, McCartney S, Calzetti F, et al. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J Immunol. 2008;181(9):6563-6573.
17. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25:619-647.
18. Engering A, Van Vliet SJ, Geijtenbeek TB, Van Kooyk Y. Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood. 2002;100(5): 1780-1786.
19. Bossy D, Buckley CD, Holness CL, Littler AJ, Murray N, Collins I, et al. Epitope mapping and functional properties of anti-intercellular adhesion molecule-3 (CD50) monoclonal antibodies. Eur J Immunol. 1995;25 (2):459-465.
20. Buck T, Gonzalez LM, Lambert WC, Schwartz RA. Sweet's syndrome with hematologic disorders: a review and reappraisal. Int J Dermatol. 2008;47(8):775-782.
21. Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34-61.